-
Pharmaco-Net Powers Second Research Paper in Sciencedirect
Calici’s research team is proud to announce the publication of our second co-authored paper.This study centers on blood glucose regulation through activation of the insulin signaling pathway, presenting significant…
-
Pharmaco-Net Powers First Research Paper in PNAS
We are proud to announce that the first customer-led publication utilizing Pharmaco-Net, Calici’s protein structure-based AI drug discovery platform, has been published in Proceedings of the National Academy of…
-
CellFree Sciences, MOU Signed With CALICI
CALICI and CellFree Sciences Sign Strategic Partnership to Accelerate Drug Discovery between Korea and Japan CALICI, a protein structure-based AI drug discovery (SBDD) company headquartered in the U.S. and…